2020
DOI: 10.21037/tcr-19-2739
|View full text |Cite
|
Sign up to set email alerts
|

Developing prognostic gene panel of survival time in lung adenocarcinoma patients using machine learning

Abstract: Background Transcriptome data generates massive amounts of information that can be used for characterization and prognosis of patient outcomes for many diseases. The goal of our research is to predict the survival time of lung adenocarcinoma patients and improve the accuracy of classifying the long-survival cohort and short-survival cohort. Methods We filtered prognostic features related with survival time of lung adenocarcinoma patients by the method of Relief and pred… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 22 publications
0
1
0
Order By: Relevance
“…In their model, they tested four microarray gene expression datasets and achieved an overall accuracy of 83.0% with only five identified genes correlated with survival time. Liu et al [124] also utilized gene expression data for a 3-year survival classification. Unlike Chen et al [123] , the authors integrated three types of sequencing data — RNA sequencing, DNA methylation, and DNA mutation — to select a total of 22 genes to improve their model’s stability.…”
Section: Apply ML To Lung Cancer Treatment Response and Survival Pred...mentioning
confidence: 99%
“…In their model, they tested four microarray gene expression datasets and achieved an overall accuracy of 83.0% with only five identified genes correlated with survival time. Liu et al [124] also utilized gene expression data for a 3-year survival classification. Unlike Chen et al [123] , the authors integrated three types of sequencing data — RNA sequencing, DNA methylation, and DNA mutation — to select a total of 22 genes to improve their model’s stability.…”
Section: Apply ML To Lung Cancer Treatment Response and Survival Pred...mentioning
confidence: 99%